Censorship in science: How publishing decisions could have shaped the perceived “general consensus” on COVID-19 vaccine safety and efficacy

Panagis Polykretis1,2, Janci C. Lindsay3, Patrizia Gentilini1,2, Nafuko Konishi4 and Masanori Fukushima5 1 “Allineare Sanità e Salute” Foundation, Milano 20131, Italy 2 Independent Medical Scientific Commission (CMSi), Milano 20122, Italy 3 Toxicology and Molecular Biology, Toxicology Support Services, LLC., Sealy, TX 77474, USA 4 Osaka Metropolitan University School of Medicine, Osaka 545-0051, Japan 5 Learning Health Society Institute, Nagoya 450-0003, Japan Correspondence to: Panagis Polykretis, email:panagis.polykretis@gmail.com Keywords: cancer; haematopoietic malignancies; COVID-19; mRNA COVID-19 vaccine Received: December 26, 2025 Accepted: January 19, 2026 Published: February 06, 2026 Copyright: © 2026 Polykretis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.